Stay updated with breaking news from Cell Ina Box. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value ...
PharmaCyte Biotech, Inc. today announces the final results of its previously announced tender offer to acquire up to 7,750,000 million shares of the Company’s common stock, par value $0.001... | June 15, 2023
Concurrently, the Company Announces $35 Million Financing of Convertible Preferred Stock at $4.00 per Share ... | May 11, 2023